Tag: biochemical recurrence

Months after finishing radiation for prostate cancer, many men watch their PSA tick upward and brace for the worst. Often, though, it's a false alarm: a 'PSA bounce' that settles on its own and may even signal a stronger response to treatment. The real task is telling a harmless bounce apart from a true recurrence, and a handful of clinical clues make that possible. keep reading

Focal therapy matches radical prostatectomy in prostate cancer control while offering fewer side effects and preserving treatment choices if cancer returns. Evidence supports its effectiveness for men with localized disease. keep reading

UPDATE: 11/21/2025 Originally published Mar. 11, 2024 The blog below announced news that before radical prostatectomy (RP), multiparametric MRI findings can predict if a prostate cancer (PCa) patient is at risk of recurrence after RP. Prior to MRI predictions, the CAPRA-S score had become the gold standard for predicting biochemical recurrence risk—but only after the surgery was done. Thus, keep reading

Emerging research reveals that early PSA after radiation and androgen deprivation therapy can help predict prostate cancer outcomes. Meanwhile, a new genomic test is showing potential for identifying which patients face higher risk of long-term urinary side effects. keep reading

Radiation doesn’t always mean the end of prostate cancer. Could focal therapy offer hope for recurrence? A new study on MRI-guided TULSA sheds light on benefits—and risks—that patients should know. keep reading

In the world of prostate cancer (PCa), there is a dangerous cell pattern called cribriform (pronounced crib’ ri-form) or simply Cr. It has a distinctive appearance that looks similar to a sieve or a plate with lots of holes. Cr is associated with aggressive Gleason grade 4 cancer. Also, there is another PCa type called keep reading

What does it mean when PSA levels rise after prostate cancer treatment—even years later? For many men, that first hint of a change can be both unsettling and significant. Catching biochemical recurrence early with scheduled PSA testing remains one of the most effective ways to stay ahead of potential cancer activity. keep reading

“We got it all and you’ll never have to worry about prostate cancer again.” Those are the sweetest words for patients with prostate cancer (PCa) who decide to have a radical prostatectomy (RP), meaning surgical removal of the entire gland. “Never again” is the hope and the expectation, and most of the time that prediction keep reading

If you were a kid in the 1960s, you may recall listening to the exciting audio countdown for NASA’s first rocket launches: “Liftoff at T minus 10 seconds. 10, 9, 8, 7, 6, 5, 4, 3, 2, 1, zero…and we have liftoff!” Since then, zero has been dropped from the countdown. In fact, it has keep reading

Dr. Mark Scholz (Prostate Cancer Research Institute) is a respected authority on prostate cancer (PCa). Many patients subscribe to the PCRI youtube channel where he responds to questions his viewers post at his channel. Since he is an oncologist, the questions he’s asked often refer to advanced or metastatic PCa. Sometimes, though, he addresses topics keep reading